WFDC2 and cancer: Moreover we observed all the parameters’ concentrations significantly different comparing every stage of advancement (I-IV) of studied cancer with the same control group: I - p < 0.001 (VEGF and CA125), p = 0.0168 (HE4); II - p = 0.0187, p < 0.001, p = 0.0023; III - p < 0.001 (respectively); IV - p = 0.0281 (VEGF) p < 0.001 (CA125 and HE4).